miR-494-3p modulates the progression of in vitro and in vivo Parkinson’s disease models by targeting SIRT3
Authors:
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 675, 23-30
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- microRNAs involved in Parkinson's disease: A systematic reviewMolecular Medicine Reports, 2016
- Sirtuins as modifiers of Parkinson's disease pathologyJournal of Neuroscience Research, 2016
- miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma CellsCellular and Molecular Neurobiology, 2015
- Bioinformatic analysis of microRNA expression in Parkinson’s diseaseMolecular Medicine Reports, 2014
- MicroRNA-494 reduces DJ-1 expression and exacerbates neurodegenerationNeurobiology of Aging, 2014
- Parkinson disease: from pathology to molecular disease mechanismsFree Radical Biology and Medicine, 2013
- Alterations of the microRNA network cause neurodegenerative diseaseTrends in Neurosciences, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Epidemiology of Parkinson's diseaseThe Lancet Neurology, 2006
- The genetic epidemiology of neurodegenerative diseaseJournal of Clinical Investigation, 2005